Physician profile
David Alan Hinkle
NPI 1013981430
$8,670.95
in general payments reported to CMS, 2019-2025
11 companies · $96.27 in 2025
The $96.27 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,172 · 2020: $2,940 · 2021: $708 · 2022: $156 · 2023: $21.55 · 2024: $1,577 · 2025: $96.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,137 · Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,136.55 |
| Food and Beverage | $558.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $3,573.41 | 2020-2021 | |
| Acorda Therapeutics, INC | $2,838.09 | 2019 | |
| Medtronic, INC. | $1,493.66 | 2024 | Activa PC, Percept PC Brainsense |
| Abbvie INC. | $246.39 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $205.60 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $128.35 | 2022 | |
| Genzyme Corporation | $87.33 | 2019 | |
| Biogen, INC. | $43.17 | 2021 | |
| Eyepoint US, INC. | $31.53 | 2021 | |
| Tms Neurohealth Centers INC. | $23.42 | 2025 | Tms Neurohealth Centers INC. |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.